Sorrento Therapeutics Inc (NASDAQ:SRNE)

8.75
Delayed Data
As of Feb 16
 -0.30 / -3.31%
Today’s Change
1.50
Today|||52-Week Range
9.55
+130.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$694.1M

Company Description

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.

Contact Information

Sorrento Therapeutics, Inc.
4955 Directors Place
San Diego California 92121
P:(858) 203-4100
Investor Relations:

Employees

Shareholders

Other institutional8.54%
Individual stakeholders41.04%
Mutual fund holders4.54%

Top Executives

Henry H. JiChairman, President & Chief Executive Officer
John LiatosChief Financial Officer
Jerome B. ZeldisChief Medical Officer
George K. NgEVP, Chief Administrative & Chief Legal Officer
Miranda ToledanoExecutive Vice President-Corporate Development